# Effects of dual-wavelength laser combined with periodontal flap surgery on periodontal parameters and inflammatory factors in patients with periodontic-endodontic lesions

**Authors:** Lijie Xu, Yanjie Chai, Shenxi Yao, Meijie Shen

PMC · DOI: 10.3389/fcimb.2026.1773155 · Frontiers in Cellular and Infection Microbiology · 2026-03-16

## TL;DR

Using a dual-wavelength laser with periodontal surgery improves healing and reduces inflammation in patients with periodontic-endodontic lesions.

## Contribution

This study demonstrates that dual-wavelength laser therapy enhances periodontal flap surgery outcomes in PEL patients.

## Key findings

- The study group showed significantly lower pain scores on day 1 post-surgery compared to the control group.
- Dual-wavelength laser treatment led to greater reductions in periodontal parameters and inflammatory markers like IL-1β, IL-6, and MMP-8.
- The study group had higher bacterial clearance rates and better long-term clinical outcomes at 6 months.

## Abstract

This study investigated the clinical effectiveness of dual-wavelength laser with periodontal flap surgery in managing periodontic-endodontic lesions (PEL) and its impact on periodontal parameters and inflammatory markers.

A total of 106 PEL patients were randomly assigned to a study group or a control group (53 each). All patients first received root canal treatment. The control group underwent conventional periodontal flap surgery, whereas the study group received adjunctive dual-wavelength laser treatment (Nd: YAG for root canal disinfection and Er: YAG for periodontal pocket debridement). Pain visual analogue scale (VAS) scores were recorded prior to treatment and at 1 and 7 days postoperatively. Periodontal parameters, gingival crevicular fluid (GCF) and serum inflammatory markers, and bacterial infection/clearance rates were assessed at baseline and 3 months post-treatment. Clinical efficacy and incidences of tooth mobility, periodontitis recurrence, and percussion pain were evaluated at 6 months.

Ninety-nine patients completed follow-up (48 in the study group and 51 in the control group). On postoperative day 1, VAS scores increased in both groups but were significantly lower in the study group (P < 0.05); by day 7, VAS scores declined with no between-group difference (P > 0.05). At 3 months, PD, CAL, GI, PLI, and levels of IL-1β, IL-6, and MMP-8 decreased in both groups, with greater improvements in the study group (P < 0.05). The study group also exhibited lower bacterial infection rates and higher bacterial clearance (P < 0.05). At 6 months, the study group showed higher treatment success and lower rates of tooth mobility, recurrence, and percussion pain (P < 0.05).

Dual-wavelength laser adjunctive therapy enhances the clinical efficacy of periodontal flap surgery in PEL, significantly improving periodontal healing, reducing inflammation, and promoting bacterial clearance.

## Linked entities

- **Proteins:** IL1B (interleukin 1 beta), IL6 (interleukin 6), MMP8 (matrix metallopeptidase 8)
- **Diseases:** periodontitis (MONDO:0005076)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MMP8 (matrix metallopeptidase 8) [NCBI Gene 4317] {aka CLG1, HNC, MMP-8, PMNL-CL}, SERPINF2 (serpin family F member 2) [NCBI Gene 5345] {aka A2AP, AAP, ALPHA-2-PI, API, PLI, alpha2AP}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** bacterial infection (MESH:D001424), tooth mobility (MESH:D014086), PEL (MESH:D010510), GI (MESH:D006470), PD (MESH:D010300), Pain (MESH:D010146), inflammation (MESH:D007249), periodontitis (MESH:D010518)
- **Chemicals:** Er: YAG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13033715/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC13033715/full.md

---
Source: https://tomesphere.com/paper/PMC13033715